Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
FTRE Stock Forecast 2026-2027
$15.43
Current Price
$1.46B
Market Cap
Buy 5
Hold 6
Sell 1
Wall St Analyst Ratings
Distance to FTRE Price Targets
+29.6%
To High Target of $20.00
+3.7%
To Median Target of $16.00
-38.4%
To Low Target of $9.50
FTRE Price Momentum
+26.7%
1 Week Change
+64.5%
1 Month Change
+150.9%
1 Year Change
-10.6%
Year-to-Date Change
-17.4%
From 52W High of $18.67
+288.7%
From 52W Low of $3.97
📊 TOP ANALYST CALLS
Did FTRE Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Fortrea is one of their latest high-conviction picks.
Latest FTRE Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, FTRE has a neutral consensus with a median price target of $16.00 (ranging from $9.50 to $20.00). The overall analyst rating is Buy (7.5/10). Currently trading at $15.43, the median forecast implies a 3.7% upside. This outlook is supported by 5 Buy, 6 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Patrick Donnelly at Citigroup, projecting a 29.6% upside. Conversely, the most conservative target is provided by David Windley at Jefferies, suggesting a 38.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
FTRE Analyst Ratings
5
Buy
6
Hold
1
Sell
FTRE Price Target Range
Low
$9.50
Average
$16.00
High
$20.00
Current: $15.43
Latest FTRE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for FTRE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 6, 2026 | Barclays | Luke Sergott | Equal-Weight | Maintains | $16.00 |
| May 6, 2026 | Citigroup | Patrick Donnelly | Buy | Maintains | $20.00 |
| Apr 14, 2026 | Barclays | Luke Sergott | Equal-Weight | Maintains | $11.00 |
| Apr 8, 2026 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $14.00 |
| Mar 9, 2026 | TD Cowen | Charles Rhyee | Buy | Upgrade | $15.00 |
| Feb 27, 2026 | Baird | Eric Coldwell | Outperform | Maintains | $16.00 |
| Feb 27, 2026 | Barclays | Luke Sergott | Equal-Weight | Maintains | $12.00 |
| Jan 22, 2026 | TD Cowen | Charles Rhyee | Hold | Maintains | $15.00 |
| Jan 8, 2026 | Truist Securities | Jailendra Singh | Buy | Upgrade | $22.00 |
| Jan 6, 2026 | Evercore ISI Group | Elizabeth Anderson | Outperform | Upgrade | $25.00 |
| Dec 18, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $13.00 |
| Dec 15, 2025 | Barclays | Luke Sergott | Equal-Weight | Upgrade | $15.00 |
| Dec 11, 2025 | Citigroup | Patrick Donnelly | Buy | Upgrade | $21.00 |
| Nov 6, 2025 | Barclays | Luke Sergott | Underweight | Maintains | $10.00 |
| Oct 17, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $9.00 |
| Oct 8, 2025 | Evercore ISI Group | Elizabeth Anderson | In-Line | Maintains | $11.00 |
| Oct 2, 2025 | Barclays | Luke Sergott | Underweight | Maintains | $8.00 |
| Sep 9, 2025 | Jefferies | David Windley | Hold | Maintains | $9.50 |
| Sep 3, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $14.00 |
| Aug 8, 2025 | Evercore ISI Group | Elizabeth Anderson | In-Line | Maintains | $7.00 |
Fortrea Holdings Inc. (FTRE) Competitors
The following stocks are similar to Fortrea based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Fortrea Holdings Inc. (FTRE) Financial Data
Fortrea Holdings Inc. has a market capitalization of $1.46B with a P/E ratio of 522.3x. The company generates $2.71B in trailing twelve-month revenue with a -16.5% profit margin.
Revenue growth is -2.3% quarter-over-quarter, while maintaining an operating margin of +0.5% and return on equity of -64.5%.
Valuation Metrics
Market Cap
$1.46B
Enterprise Value
$2.45B
P/E Ratio
522.3x
PEG Ratio
-10.8x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
-2.3%
Gross Margin
+19.8%
Operating Margin
+0.5%
Net Margin
-16.5%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+10.1%
Current Ratio
0.9x
Debt/Equity
212.7x
ROE
-64.5%
ROA
-0.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Fortrea Holdings Inc. (FTRE) Business Model
About Fortrea Holdings Inc.
What They Do
Provides clinical development solutions for biopharmaceuticals.
Business Model
The company operates as a contract research organization (CRO), generating revenue by offering a range of clinical trial management services across various phases and therapeutic areas. It serves biopharmaceutical, biotechnology, and medical device companies, utilizing flexible delivery models to cater to client needs and streamline trial processes.
Additional Information
Incorporated in 2023 and headquartered in Durham, North Carolina, the company operates in about 90 countries. Fortrea Holdings emphasizes innovation through decentralized trials and technology integration, aiming to accelerate drug development timelines and enhance efficiency in clinical research.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
13,871
CEO
Mr. Anshul Thakral
Country
United States
IPO Year
2023
Website
www.fortrea.comFortrea Holdings Inc. (FTRE) Latest News & Analysis
Latest News
Quick Summary
Fortrea Holdings Inc. (FTRE) held its Q1 2026 earnings call, discussing financial performance and future outlook. Further details are available in the transcript.
Why It Matters
The Q1 2026 earnings call for Fortrea Holdings Inc. provides insights into financial performance, growth prospects, and market positioning, influencing investor sentiment and valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Fortrea Reports First Quarter 2026 Results
4 days ago
Quick Summary
The company reported a strong first-quarter performance, reinforcing its FY 2026 guidance. It achieved a book-to-bill ratio of 1.15x for the third consecutive quarter.
Why It Matters
Strong Q1 results and a consistent book-to-bill ratio above 1.1x signal robust demand, enhancing confidence in future earnings and growth prospects for FY 2026.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Fortrea Holdings Inc. (FTRE) reported quarterly earnings of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.03 and up from $0.02 per share a year earlier.
Why It Matters
Fortrea's significant earnings beat signals strong financial performance and growth potential, likely boosting investor confidence and positively impacting stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Fortrea Holdings Inc. (FTRE) is expected to lack the necessary factors for a potential earnings beat in its upcoming report. Investors should prepare for this information.
Why It Matters
Fortrea Holdings Inc. may underperform in its upcoming earnings report, signaling potential volatility in its stock price and impacting investor sentiment and decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Fortrea (Nasdaq: FTRE) will release Q1 2026 financial results on May 5, 2026, before market opens, followed by a conference call at 8:00 a.m. ET.
Why It Matters
Fortrea's upcoming Q1 2026 financial results and conference call may influence stock performance and investor sentiment, impacting trading decisions and market perceptions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Fortrea (Nasdaq: FTRE) launched Fortrea Intelligent Technology™ (FIT) to enhance clinical trial operations with AI-powered solutions, improving speed, predictability, and quality.
Why It Matters
Fortrea's launch of AI-driven technology solutions enhances clinical trial efficiency, potentially increasing profitability and market competitiveness, making it a significant development for shareholders.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About FTRE Stock
What is Fortrea Holdings Inc.'s (FTRE) stock forecast for 2026?
Based on our analysis of 13 Wall Street analysts, Fortrea Holdings Inc. (FTRE) has a median price target of $16.00. The highest price target is $20.00 and the lowest is $9.50.
Is FTRE stock a good investment in 2026?
According to current analyst ratings, FTRE has 5 Buy ratings, 6 Hold ratings, and 1 Sell ratings. The stock is currently trading at $15.43. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for FTRE stock?
Wall Street analysts predict FTRE stock could reach $16.00 in the next 12 months. This represents a 3.7% increase from the current price of $15.43. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Fortrea Holdings Inc.'s business model?
The company operates as a contract research organization (CRO), generating revenue by offering a range of clinical trial management services across various phases and therapeutic areas. It serves biopharmaceutical, biotechnology, and medical device companies, utilizing flexible delivery models to cater to client needs and streamline trial processes.
What is the highest forecasted price for FTRE Fortrea Holdings Inc.?
The highest price target for FTRE is $20.00 from Patrick Donnelly at Citigroup, which represents a 29.6% increase from the current price of $15.43.
What is the lowest forecasted price for FTRE Fortrea Holdings Inc.?
The lowest price target for FTRE is $9.50 from David Windley at Jefferies, which represents a -38.4% decrease from the current price of $15.43.
What is the overall FTRE consensus from analysts for Fortrea Holdings Inc.?
The overall analyst consensus for FTRE is neutral. Out of 13 Wall Street analysts, 5 rate it as Buy, 6 as Hold, and 1 as Sell, with a median price target of $16.00.
How accurate are FTRE stock price projections?
Stock price projections, including those for Fortrea Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 9, 2026 7:24 AM UTC